Full Coverage

Skyepharma PLC - Interim Management Statement

                   
pharmiweb.co.uk
19-May-2008
        
Story Timeline:  200 days

FOR IMMEDIATE RELEASE SKYEPHARMA PLC - Detailed work is now being carried out with a view to making a proposal to key bondholders and announcing definitive plans for refinancing or renegotiating the bonds shortly after the announcement of the results of the further two pivotal Phase III efficacy... [read full story]                    

Add Comment
Latest article on this story:

Skyepharma PLC - AGM Statement

 pharmiweb.co.uk 21-May-2008
First article on this story:

Skyepharma PLC: Skyepharma PLC - Interim Management Statement

 marketwire.com 19-May-2008
Selected publications with coverage of this story:
marketwire.com yahoo.com earthtimes.org tmcnet.com pharmiweb.co.uk
RELATED
Found 5 documents:

Skyepharma PLC - AGM Statement

pharmiweb.co.uk
21-May-2008
        

SKYEPHARMA PLC - AGM RESULTS LONDON, UK, 21 May 2008 - SkyePharma PLC (LSE: SKP) announces the results of the voting by shareholders at the Annual General Meeting held earlier today. All resolutions were passed on a show of hands. Two copies of all resolutions passed will be submitted later today...

                   

SkyePharma PLC announces Succession Plan

pharmiweb.co.uk
21-May-2008
        

Wednesday May 21, 1:59 am ET Succession Plan LONDON, UK, 21 May 2008 - News) will announce that its Chief Executive Officer, Frank Condella, intends to step down from his executive position once the Company has completed its financial restructuring by refinancing or renegotiating its convertible...

                   

SkyePharma PLC announces Succession Plan

earthtimes.org
21-May-2008
        

Succession Plan LONDON, UK, 21 May 2008 - At its Annual General Meeting later today, SkyePharma PLC (LSE: SKP) will announce that its Chief Executive Officer, Frank Condella, intends to step down from his executive position once the Company has completed its financial restructuring by refinancing...

Skyepharma PLC announces Research Update

pharmiweb.co.uk
20-May-2008
        

SkyePharma Announces Presentation of FlutiformTM Phase III Safety Study at ATS in Toronto LONDON, UK, 20 May, 2008 - The author of the poster, Dr. Ekkehard Beck, stated "Study results suggest that long term treatment with FlutiformTM 100/10?g and FlutiformTM 250/10?g will be a safe therapy for...

Skyepharma PLC announces Research Update

earthtimes.org
20-May-2008
        

SkyePharma Announces Presentation of FlutiformTM Phase III Safety Study at ATS in Toronto LONDON, UK, 20 May, 2008 - The author of the poster, Dr. Ekkehard Beck, stated "Study results suggest that long term treatment with FlutiformTM 100/10?g and FlutiformTM 250/10?g will be a safe therapy for...